Attovia Therapeutics, Inc. (ATTO)

Attovia Therapeutics will go public soon, but the exact IPO date is still unknown.

Stock Price: Pending

IPO price not available yet

Attovia Therapeutics Statistics

Total Valuation

Market Cap	n/a
Enterprise Value	n/a

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	10.39

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	n/a
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	$30,682
Profits Per Employee	-$1.46M
Employee Count	44
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	n/a
200-Day Moving Average	n/a
Relative Strength Index (RSI)	n/a
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ATTO had revenue of $1.35 million and -$64.13 million in losses.

Revenue	1.35M
Gross Profit	1.35M
Operating Income	-71.01M
Pretax Income	-64.13M
Net Income	-64.13M
EBITDA	-70.06M
EBIT	-70.96M
Earnings Per Share (EPS)	n/a

Full Income Statement

Balance Sheet

The company has $132.62 million in cash and $4.80 million in debt, with a net cash position of $127.82 million.

Cash & Cash Equivalents	132.62M
Total Debt	4.80M
Net Cash	127.82M
Net Cash Per Share	n/a
Equity (Book Value)	-125.52M
Book Value Per Share	n/a
Working Capital	126.84M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$63.21 million and capital expenditures -$809,000, giving a free cash flow of -$64.02 million.

Operating Cash Flow	-63.21M
Capital Expenditures	-809,000
Depreciation & Amortization	903,000
Net Borrowing	n/a
Free Cash Flow	-64.02M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of -5,260.00% and -4,750.52%.

Gross Margin	100.00%
Operating Margin	-5,260.00%
Pretax Margin	-4,750.52%
Profit Margin	-4,750.52%
EBITDA Margin	-5,189.33%
EBIT Margin	-5,256.22%
FCF Margin	-4,742.07%

Dividends & Yields

ATTO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	n/a
FCF Yield	n/a

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (3Y)	n/a
EPS Growth Forecast (3Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a